Purchase Order 75N91023P00720
Award Date 8/22/23
Potential Completion Date 11/21/23
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,700 firm fixed price purchase order to Human Metabolome Technologies America, Inc. to provide laboratory and testing services, including an Omega Scan option with no additional cost. The place of performance will be in Bethesda, Maryland. The contract period of performance spans from August 1, 2023 through November 30, 2023. No subcontractors or set aside designations were...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,570 purchase order to Oxford Nanopore Technologies Inc. for laboratory supplies. The firm fixed price contract runs from August 17, 2023 to January 5, 2024 and will be performed in New York, New York. As the National Cancer Institute supports research to advance cancer prevention, diagnosis, and treatment, this contract will likely provide supplies to enable NCI-funded laboratory...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. for laboratory equipment. The firm fixed price contract has a period of performance from September 6, 2023 through October 28, 2023 and will be performed in Wellesley Hills, Massachusetts. No additional details were provided regarding the specific laboratory equipment being procured. The National Cancer Institute conducts and supports...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded an approximately $11,000 purchase order to Global Life Sciences Solutions USA LLC for maintenance services. The prime contractor, a subsidiary of Danaher Corporation, will perform the work in Marlborough, Massachusetts over a one-year base period ending in December 2024. The contract has a firm fixed price and no set-aside designation. The National Cancer Institute is a part of NIH focused...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at forty-seven thousand two hundred forty-two dollars and six cents ($47,242.06) to Metabolon, Inc. to measure metabolomic and lipidomic concentrations on fifty-eight incident pancreatic cancer cases and fifty-eight controls, along with six blinded replicate quality control samples, totaling one hundred twenty-two...
- This federal contract award from the Department of Health and Human Services' National Institutes of Health's National Cancer Institute is for laboratory supplies with a potential value of fourteen thousand four hundred seventy-eight dollars and fifty-two cents ($14,478.52). Life Technologies Corporation of Billerica, Massachusetts has been awarded a firm fixed price call against a blanket purchase agreement to deliver the requested lab supplies by January 31, 2024 in support of the National...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National Cancer Institute's research efforts to better understand disease mechanisms and develop new treatment strategies in the fight against cancer.
Generated 12/19/23, 6:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 8/7/23 |